Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH).

Nordmann S, Vilotitch A, Roux P, Esterle L, Spire B, Marcellin F, Salmon-Ceron D, Dabis F, Chas J, Rey D, Wittkop L, Sogni P, Carrieri P; ANRS CO13 HEPAVIH Study Group.

J Viral Hepat. 2017 Oct 6. doi: 10.1111/jvh.12797. [Epub ahead of print]

PMID:
28984055
2.

Evaluation of a new random-access HBV DNA molecular assay: The VERIS HBV assay.

Fourati S, Challine D, Poveda JD, Laperche S, Rallier S, Pawlotsky JM, Chevaliez S.

J Clin Virol. 2017 Jul;92:69-74. doi: 10.1016/j.jcv.2017.05.015. Epub 2017 May 17.

PMID:
28549336
3.

Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral-Experienced Patients With Hepatitis C.

Hézode C, Fourati S, Chevaliez S, Scoazec G, Soulier A, Varaut A, François M, Ruiz I, Roudot-Thoraval F, Mallat A, Pawlotsky JM.

Clin Infect Dis. 2017 Jun 1;64(11):1615-1618. doi: 10.1093/cid/cix214.

PMID:
28369411
4.

Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.

Vaccari M, Gordon SN, Fourati S, Schifanella L, Liyanage NP, Cameron M, Keele BF, Shen X, Tomaras GD, Billings E, Rao M, Chung AW, Dowell KG, Bailey-Kellogg C, Brown EP, Ackerman ME, Vargas-Inchaustegui DA, Whitney S, Doster MN, Binello N, Pegu P, Montefiori DC, Foulds K, Quinn DS, Donaldson M, Liang F, Loré K, Roederer M, Koup RA, McDermott A, Ma ZM, Miller CJ, Phan TB, Forthal DN, Blackburn M, Caccuri F, Bissa M, Ferrari G, Kalyanaraman V, Ferrari MG, Thompson D, Robert-Guroff M, Ratto-Kim S, Kim JH, Michael NL, Phogat S, Barnett SW, Tartaglia J, Venzon D, Stablein DM, Alter G, Sekaly RP, Franchini G.

Nat Med. 2016 Oct 6;22(10):1192. doi: 10.1038/nm1016-1192a. No abstract available.

PMID:
27711066
5.

Recent advances in understanding and diagnosing hepatitis B virus infection.

Fourati S, Pawlotsky JM.

F1000Res. 2016 Sep 6;5. pii: F1000 Faculty Rev-2243. doi: 10.12688/f1000research.8983.1. eCollection 2016. Review.

6.

Systems biology and the quest for correlates of protection to guide the development of an HIV vaccine.

Kuri-Cervantes L, Fourati S, Canderan G, Sekaly RP.

Curr Opin Immunol. 2016 Aug;41:91-97. doi: 10.1016/j.coi.2016.06.010. Epub 2016 Jul 5. Review.

PMID:
27392184
7.

Automated quantification of Epstein-Barr Virus in whole blood of hematopoietic stem cell transplant patients using the Abbott m2000 system.

Salmona M, Fourati S, Feghoul L, Scieux C, Thiriez A, Simon F, Resche-Rigon M, LeGoff J.

Diagn Microbiol Infect Dis. 2016 Aug;85(4):428-32. doi: 10.1016/j.diagmicrobio.2016.04.017. Epub 2016 Apr 28.

PMID:
27312691
8.

Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.

Vaccari M, Gordon SN, Fourati S, Schifanella L, Liyanage NP, Cameron M, Keele BF, Shen X, Tomaras GD, Billings E, Rao M, Chung AW, Dowell KG, Bailey-Kellogg C, Brown EP, Ackerman ME, Vargas-Inchaustegui DA, Whitney S, Doster MN, Binello N, Pegu P, Montefiori DC, Foulds K, Quinn DS, Donaldson M, Liang F, Loré K, Roederer M, Koup RA, McDermott A, Ma ZM, Miller CJ, Phan TB, Forthal DN, Blackburn M, Caccuri F, Bissa M, Ferrari G, Kalyanaraman V, Ferrari MG, Thompson D, Robert-Guroff M, Ratto-Kim S, Kim JH, Michael NL, Phogat S, Barnett SW, Tartaglia J, Venzon D, Stablein DM, Alter G, Sekaly RP, Franchini G.

Nat Med. 2016 Jul;22(7):762-70. doi: 10.1038/nm.4105. Epub 2016 May 30.

PMID:
27239761
9.

Zika Virus Associated with Meningoencephalitis.

Carteaux G, Maquart M, Bedet A, Contou D, Brugières P, Fourati S, Cleret de Langavant L, de Broucker T, Brun-Buisson C, Leparc-Goffart I, Mekontso Dessap A.

N Engl J Med. 2016 Apr 21;374(16):1595-6. doi: 10.1056/NEJMc1602964. Epub 2016 Mar 9. No abstract available.

10.

Laboratory-based strategy using a new marketed polymerase chain reaction assay to manage diarrheic episodes among patients from rehabilitation and long-term care facilities.

Salmona M, Jolivet S, Duprilot M, Akpabie AC, Fourati S, Decousser JW.

Am J Infect Control. 2016 Jun 1;44(6):716-8. doi: 10.1016/j.ajic.2015.12.027. Epub 2016 Feb 24.

11.

Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination.

Fourati S, Cristescu R, Loboda A, Talla A, Filali A, Railkar R, Schaeffer AK, Favre D, Gagnon D, Peretz Y, Wang IM, Beals CR, Casimiro DR, Carayannopoulos LN, Sékaly RP.

Nat Commun. 2016 Jan 8;7:10369. doi: 10.1038/ncomms10369.

12.

Virologic Tools for HCV Drug Resistance Testing.

Fourati S, Pawlotsky JM.

Viruses. 2015 Dec 4;7(12):6346-59. doi: 10.3390/v7122941. Review.

13.

Sequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement.

Solis M, Meddeb M, Sueur C, Domingo-Calap P, Soulier E, Chabaud A, Perrin P, Moulin B, Bahram S, Stoll-Keller F, Caillard S, Barth H, Fafi-Kremer S; French BKV Study Group.

J Clin Microbiol. 2015 Dec;53(12):3842-52. doi: 10.1128/JCM.02145-15. Epub 2015 Oct 14.

14.

Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage.

Alteri C, Surdo M, Bellocchi MC, Saccomandi P, Continenza F, Armenia D, Parrotta L, Carioti L, Costa G, Fourati S, Di Santo F, Scutari R, Barbaliscia S, Fedele V, Carta S, Balestra E, Alcaro S, Marcelin AG, Calvez V, Ceccherini-Silberstein F, Artese A, Perno CF, Svicher V.

Antimicrob Agents Chemother. 2015 Aug;59(8):4870-81. doi: 10.1128/AAC.00137-15. Epub 2015 Jun 8.

15.

Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy.

Hattab S, Guiguet M, Carcelain G, Fourati S, Guihot A, Autran B, Caby F, Marcelin AG, Costagliola D, Katlama C.

HIV Med. 2015 Oct;16(9):553-62. doi: 10.1111/hiv.12257. Epub 2015 May 6.

16.

HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.

Frange P, Assoumou L, Descamps D, Chéret A, Goujard C, Tran L, Gousset M, Avettand-Fenoël V, Bocket L, Fafi-Kremer S, Guinard J, Morand-Joubert L, Nicot F, Plantier JC, Rogez S, Wirden M, Rouzioux C, Meyer L, Chaix ML; French ANRS CO 6 PRIMO Cohort, the ANRS 147 OPTIPRIM Clinical Trial and the AC11 Resistance Study Groups; French ANRS CO 6 PRIMO Cohort the ANRS 147 OPTIPRIM Clinical Trial and the AC11 Resistance Study Groups.

J Antimicrob Chemother. 2015 Jul;70(7):2084-9. doi: 10.1093/jac/dkv049. Epub 2015 Feb 26.

PMID:
25885327
17.

Correction: Musosal effects for tenofovir 1% gel.

Hladik F, Burgener A, Ballweber L, Gottardo R, Vojtech L, Fourati S, Dai JY, Cameron MJ, Strobl J, Hughes SM, Hoesley C, Andrew P, Johnson S, Piper J, Friend DR, Ball TB, Cranston RD, Mayer KH, McElrath MJ, McGowan I.

Elife. 2015 Mar 24;4. doi: 10.7554/eLife.07586. No abstract available.

18.

Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH).

Carrieri MP, Serfaty L, Vilotitch A, Winnock M, Poizot-Martin I, Loko MA, Lions C, Lascoux-Combe C, Roux P, Salmon-Ceron D, Spire B, Dabis F; ANRS CO13 HEPAVIH Study Group.

Clin Infect Dis. 2015 Jul 1;61(1):40-8. doi: 10.1093/cid/civ217. Epub 2015 Mar 16.

PMID:
25778750
19.

Virological failure of patients on maraviroc-based antiretroviral therapy.

Raymond S, Maillard A, Amiel C, Peytavin G, Trabaud MA, Desbois D, Bellecave P, Delaugerre C, Soulie C, Marcelin AG, Descamps D, Izopet J; on behalf the ANRS AC11 Resistance Study Group.

J Antimicrob Chemother. 2015;70(6):1858-64. doi: 10.1093/jac/dkv026. Epub 2015 Feb 19.

PMID:
25700719
20.

Mucosal effects of tenofovir 1% gel.

Hladik F, Burgener A, Ballweber L, Gottardo R, Vojtech L, Fourati S, Dai JY, Cameron MJ, Strobl J, Hughes SM, Hoesley C, Andrew P, Johnson S, Piper J, Friend DR, Ball TB, Cranston RD, Mayer KH, McElrath MJ, McGowan I.

Elife. 2015 Feb 3;4. doi: 10.7554/eLife.04525. Erratum in: Elife. 2015;4. doi: 10.7554/eLife.07586.

Supplemental Content

Loading ...
Support Center